Episodes

We conclude our series on lupus with a trip to the doctor’s office, where rheumatologist Dr. Mark Box delves into the clinical side of the disease. He explores dealing with insurance companies and preserving the doctor-patien...

This week, the Institute for Clinical and Economic Review (ICER) deliberates the fate of insurance coverage for patients with lupus. In this episode, Mollee Huffman shares her diagnosis of lupus, how it impacted her Navy care...

When a chronic condition prevents you from working, you might find yourself filling out a disability claim. But what happens when it’s denied? And how can you fight to receive your health benefits? All of this ties back to ER...

If you have trouble adhering to your medication regimen or know you need to eat healthier, but are overwhelmed, tiny habits may be your answer. Examining your small habits can help patients with chronic illness live healthi...

COVID-19 has caused people to delay important cancer screenings and medical appointments. Coupled with the rising rates of colon cancer among younger adults, it’s clear the healthcare industry must change its approach to scre...

Rare Disease Day is February 28. New and exciting medical innovations and drug therapies for rare disease abound, but accessing those treatments is another challenge. Discriminatory healthcare metrics like quality-adjusted-li...

Minority communities are underrepresented in healthcare leadership roles. By dismantling systemic barriers, the entire healthcare industry can benefit from talented professionals, scientists, and researchers from diverse back...

Digital tech became a major healthcare tool during the pandemic. And AI-powered prescription drug apps are leading the charge in creating accessible and affordable medications. So how can these apps help patients take control...

Underserved communities are at higher risk for COVID, but they’re getting vaccinated at a slower pace. How do we correct a healthcare system that fails to serve all Americans? Dennis Johnson joins the show to share lessons le...

Congress may soon revisit legislation to tackle the high costs of prescription drugs under Medicare. But drug pricing is never a simple fix. Guest Peter Pitts explains the ins and outs of drug pricing. Plus, Terry and Bob dis...

Vaccine distribution is off to a rocky start. While some states are exceeding expectations, others continue to lag behind. This week we grade America’s pandemic response to this point and vaccine distribution. Pandemic prepar...

With the new Hospital Price Transparency rule, patients will finally be able to view and compare the costs of services across hospitals. David Balat of Right on Healthcare joins the podcast to share how patients across the co...

Democrats soon will control Congress and the White House. What should patients with chronic conditions expect from a federal government run by Democrats who now appear to have no political obstacles for their legislative agen...

Congress and the new Biden White House are ready to hit the ground running in 2021. So we’re here to make sure patient needs are addressed and included in upcoming legislation. On this episode, Terry outlines the Pro-Patient ...

The Most Favored Nation Rule will take effect on January 1st. It’s bad news for Medicare infusion patients and providers, but there’s still time to stop it. The rule makes it financially impossible for medical practices to of...

Navigating the legal issues that come with a cancer diagnosis is challenging. From employer discrimination to financial toxicity, legal consultation provides much-needed peace of mind and guidance. Shelly Rosenfeld makes her ...

As President-elect Joe Biden makes his health team picks, we discuss what patients may expect out of a new Democratic Administration and increased Republican seats in the U.S. House. We bring policy experts from both sides o...

Can Republicans and Democrats work together to help the chronic disease community? Former FDA Commissioner Dr. Mark McClellan predicts what healthcare challenges may benefit from bipartisan support in the new year. Plus, he o...

In the wake of Alex Trebek’s passing, we take a look at the state of pancreatic cancer treatments and care. Julie Fleshman, CEO of the Pancreatic Cancer Action Network, gives insights into the increase in treatment options. P...

Precision medicine is revolutionizing cancer care. Dr. Razelle Kurzrock highlights how personalized treatments improve patient outcomes and quality of life. Plus, it’s enrollment season! Get the information you need for Medic...

Power to patients! A new price transparency rule from the U.S. Department of Health and Human Services will allow you to see exactly what you’re paying for. Terry and Dr. Bob discuss the rule that will require private insurer...

As a heated election season wraps up, Terry and Dr. Bob examine the latest results and what they mean for patients and federal healthcare policy. Dr. Madelaine Feldman discusses tactics used by pharmacy benefit managers (PBMs) to profit at the …

As a heated election season wraps up, Terry and Dr. Bob examine the latest results and what they mean for patients and federal healthcare policy. Dr. Madelaine Feldman discusses tactics used by pharmacy benefit managers (PBMs...

Gene therapies can be lifesaving for many patients. But accessing them can be a challenge of its own. Terry and Dr. Bob discuss the private sector’s work to improve accessibility with Biotech executive John Crowley, who share...